427 related articles for article (PubMed ID: 36994201)
1. Research progress of traditional Chinese medicine as sensitizer in reversing chemoresistance of colorectal cancer.
Lin X; Yang X; Yang Y; Zhang H; Huang X
Front Oncol; 2023; 13():1132141. PubMed ID: 36994201
[TBL] [Abstract][Full Text] [Related]
2. Traditional Chinese medicine for colorectal cancer treatment: potential targets and mechanisms of action.
Chen JF; Wu SW; Shi ZM; Hu B
Chin Med; 2023 Feb; 18(1):14. PubMed ID: 36782251
[TBL] [Abstract][Full Text] [Related]
3. Colorectal cancer cell-derived CCL20 recruits regulatory T cells to promote chemoresistance via FOXO1/CEBPB/NF-κB signaling.
Wang D; Yang L; Yu W; Wu Q; Lian J; Li F; Liu S; Li A; He Z; Liu J; Sun Z; Yuan W; Zhang Y
J Immunother Cancer; 2019 Aug; 7(1):215. PubMed ID: 31395078
[TBL] [Abstract][Full Text] [Related]
4. Sanguisorba officinalis L. suppresses 5-fluorouracil-sensitive and-resistant colorectal cancer growth and metastasis via inhibition of the Wnt/β-catenin pathway.
Zhang W; Peng C; Yan J; Chen P; Jiang C; Sang S; Yuan Y; Hong Y; Yao M
Phytomedicine; 2022 Jan; 94():153844. PubMed ID: 34785413
[TBL] [Abstract][Full Text] [Related]
5. [Hydroxysafflor yellow A inhibits proliferation, migration, and chemoresistance of colorectal cancer cells through Akt/mTOR-autophagy pathway].
Wang L; Li F; Gu NN; Shen H; Han CL; Li KY; Yan RY; Wang J; Mi ZK
Zhongguo Zhong Yao Za Zhi; 2023 Jan; 48(2):517-524. PubMed ID: 36725241
[TBL] [Abstract][Full Text] [Related]
6. Self-assembled traditional Chinese nanomedicine modulating tumor immunosuppressive microenvironment for colorectal cancer immunotherapy.
Mao Q; Min J; Zeng R; Liu H; Li H; Zhang C; Zheng A; Lin J; Liu X; Wu M
Theranostics; 2022; 12(14):6088-6105. PubMed ID: 36168633
[TBL] [Abstract][Full Text] [Related]
7. The Effect of Long-Term Traditional Chinese Medicine Treatment on Survival Time of Colorectal Cancer Based on propensity Score Matching: A Retrospective Cohort Study.
Wang Y; Liu P; Fang Y; Tian J; Li S; Xu J; Zhao F; Yin X; Zhang Q; Li Y
Evid Based Complement Alternat Med; 2020; 2020():7023420. PubMed ID: 32089727
[TBL] [Abstract][Full Text] [Related]
8. RBCK1 contributes to chemoresistance and stemness in colorectal cancer (CRC).
Liu ML; Zang F; Zhang SJ
Biomed Pharmacother; 2019 Oct; 118():109250. PubMed ID: 31545242
[TBL] [Abstract][Full Text] [Related]
9. B7-H3 promotes the cell cycle-mediated chemoresistance of colorectal cancer cells by regulating CDC25A.
Ma Y; Wang R; Lu H; Li X; Zhang G; Fu F; Cao L; Zhan S; Wang Z; Deng Z; Shi T; Zhang X; Chen W
J Cancer; 2020; 11(8):2158-2170. PubMed ID: 32127943
[TBL] [Abstract][Full Text] [Related]
10. A network pharmacology-based investigation on the bioactive ingredients and molecular mechanisms of Gelsemium elegans Benth against colorectal cancer.
Que W; Chen M; Yang L; Zhang B; Zhao Z; Liu M; Cheng Y; Qiu H
BMC Complement Med Ther; 2021 Mar; 21(1):99. PubMed ID: 33743701
[TBL] [Abstract][Full Text] [Related]
11. [Current status of traditional Chinese medicine on reversing tumor multi-drug resistance].
Wang YJ; Li Q; Li YJ; Yang Q; Chen Y; Weng XG; Kan XX; Chen X; Zhu XX
Zhongguo Zhong Yao Za Zhi; 2014 Dec; 39(24):4693-8. PubMed ID: 25898563
[TBL] [Abstract][Full Text] [Related]
12. Zuo Jin Wan Reverses the Resistance of Colorectal Cancer to Oxaliplatin by Regulating the MALAT1/miR-200s/JNK Signaling Pathway.
Wei Z; Zhou J; Yu H; Pu Y; Cheng Y; Zhang Y; Ji Q; Zhu H
Evid Based Complement Alternat Med; 2022; 2022():3032407. PubMed ID: 36248422
[TBL] [Abstract][Full Text] [Related]
13. Dichloroacetate Overcomes Oxaliplatin Chemoresistance in Colorectal Cancer through the miR-543/PTEN/Akt/mTOR Pathway.
Liang Y; Zhu D; Zhu L; Hou Y; Hou L; Huang X; Li L; Wang Y; Li L; Zou H; Wu T; Yao M; Wang J; Meng X
J Cancer; 2019; 10(24):6037-6047. PubMed ID: 31762813
[TBL] [Abstract][Full Text] [Related]
14. Carcinoma-associated fibroblasts promote the stemness and chemoresistance of colorectal cancer by transferring exosomal lncRNA H19.
Ren J; Ding L; Zhang D; Shi G; Xu Q; Shen S; Wang Y; Wang T; Hou Y
Theranostics; 2018; 8(14):3932-3948. PubMed ID: 30083271
[TBL] [Abstract][Full Text] [Related]
15. The Effects of Traditional Chinese Medicine on P-Glycoprotein-Mediated Multidrug Resistance and Approaches for Studying the Herb-P-Glycoprotein Interactions.
Cao Y; Shi Y; Cai Y; Hong Z; Chai Y
Drug Metab Dispos; 2020 Oct; 48(10):972-979. PubMed ID: 32816867
[TBL] [Abstract][Full Text] [Related]
16. Hedgehog-GLI and Notch Pathways Sustain Chemoresistance and Invasiveness in Colorectal Cancer and Their Inhibition Restores Chemotherapy Efficacy.
Citarella A; Catanzaro G; Besharat ZM; Trocchianesi S; Barbagallo F; Gosti G; Leonetti M; Di Fiore A; Coppola L; Autilio TM; Spinello Z; Vacca A; De Smaele E; Venneri MA; Ferretti E; Masuelli L; Po A
Cancers (Basel); 2023 Feb; 15(5):. PubMed ID: 36900263
[TBL] [Abstract][Full Text] [Related]
17. DSTYK Promotes Metastasis and Chemoresistance
Zhang J; Miller Z; Musich PR; Thomas AE; Yao ZQ; Xie Q; Howe PH; Jiang Y
Front Pharmacol; 2020; 11():1250. PubMed ID: 32982725
[TBL] [Abstract][Full Text] [Related]
18. Role of Ginseng, Quercetin, and Tea in Enhancing Chemotherapeutic Efficacy of Colorectal Cancer.
Zhao L; Zhao H; Zhao Y; Sui M; Liu J; Li P; Liu N; Zhang K
Front Med (Lausanne); 2022; 9():939424. PubMed ID: 35795631
[TBL] [Abstract][Full Text] [Related]
19. Natural products for treating colorectal cancer: A mechanistic review.
Huang XM; Yang ZJ; Xie Q; Zhang ZK; Zhang H; Ma JY
Biomed Pharmacother; 2019 Sep; 117():109142. PubMed ID: 31238258
[TBL] [Abstract][Full Text] [Related]
20. YYFZBJS ameliorates colorectal cancer progression in Apc
Sui H; Zhang L; Gu K; Chai N; Ji Q; Zhou L; Wang Y; Ren J; Yang L; Zhang B; Hu J; Li Q
Cell Commun Signal; 2020 Jul; 18(1):113. PubMed ID: 32677955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
